0001209191-17-036313.txt : 20170530
0001209191-17-036313.hdr.sgml : 20170530
20170530205311
ACCESSION NUMBER: 0001209191-17-036313
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170525
FILED AS OF DATE: 20170530
DATE AS OF CHANGE: 20170530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC
CENTRAL INDEX KEY: 0001123494
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043306140
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL RD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: 5088938999
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEWIS EARL R
CENTRAL INDEX KEY: 0001230427
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33957
FILM NUMBER: 17879301
MAIL ADDRESS:
STREET 1: C/O NXSTAGE MEDICAL INC. (NXTM)
STREET 2: 439 SOUTH UNION STREET, 5TH FLOOR
CITY: LAWRENCE
STATE: MA
ZIP: 01843
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-25
0
0001123494
HARVARD BIOSCIENCE INC
HBIO
0001230427
LEWIS EARL R
87 PINCKNEY STREET
BOSTON
MA
02114
1
0
0
0
Common Stock
2017-05-25
4
A
0
31300
0.00
A
455112
D
Common Stock
2017-05-25
4
P
0
5000
2.38
A
460112
D
Common Stock
2017-05-25
4
P
0
7238
2.33
A
467350
D
Represents a deferred stock award of 31,300 restricted stock units which fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018.
Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 9,450 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (c) 414,362 shares of common stock held by the Reporting Person.
Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 9,450 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (c) 419,362 shares of common stock held by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $2.31 to $2.34. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 9,450 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (c) 426,600 shares of common stock held by the Reporting Person.
This form has been signed under power of attorney.
/s/ Chad Porter, by power of attorney
2017-05-30